Last updated on March 2018

A Study of BCD-135 in Patients With Advanced Solid Tumors


Brief description of study

A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of Pharmacokinetics, Safety, and Immunogenicity of BCD-135 (JSC BIOCAD, Russia) in Patients with Advanced Solid Tumors

Clinical Study Identifier: NCT03464032

Find a site near you

Start Over

LLC BioEk

Saint-Petersburg, Russian Federation
  Connect »